Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

Share Price is delayed by 15 minutes
Get Live Data
5.80    -0.10 (-1.69%)
Bid:
5.70
Ask:
5.90
Spread: 0.20 (3.509%)
Market Cap: £14.92m
TEK Live PriceLast checked at - London Stock Exchange

Intraday TekCapital Share Chart

Executive Appointment

9 Oct 2018 07:00

RNS Number : 3377D
Tekcapital plc
09 October 2018
 

 

Tekcapital plc

 

("Tekcapital" or the "Company")

 

Executive Appointment

Tekcapital plc, (AIM: TEK) the UK intellectual property investment group focused on creating marketplace value from university technology, announces that Dr Mireya McKee has joined as Business Development Manager.

Mireya has over 17 years of research, technology transfer and innovation management experience. She completed a Ph. D. in biochemistry from the University of Texas-Austin as a CONACYT fellow. Afterwards, she carried out postdoctoral research in nanotechnology at Oxford University, where she received an EPSRC Developing Future Leaders-Women in Science grant.

She transitioned into business, completing a certification program on the commercialization of scientific research at Oxford's Saïd Business School. Dr McKee also served as a senior consultant in technology transfer for Oxford University Innovation (OUI).

Mireya founded an innovation management consultancy that provided training and support to universities and start-up companies around the globe. As part of this effort, she has become knowledgeable about the innovation ecosystems of Latin American countries where she has assisted a number of government agencies in designing and implementing innovation policies and programs.

Clifford M. Gross Ph.D., Chief Executive Officer of Tekcapital plc commented:

"We are enthusiastic to have Dr McKee join our team and we are confident she will help to expand our service business in Latin America."

For further information, please contact:

 

Tekcapital plc

Clifford M Gross, Ph.D.

 

Via Walbrook PR

finnCap Ltd (Nominated Adviser and Joint Broker)

 +44 (0) 20 7220 0500

Geoff Nash (Corporate Finance)

Max Bullen-Smith (Corporate Finance)

Camille Gochez (ECM)

 

Novum Securities (Joint Broker)

Colin Rowbury

 

+44 (0) 29 7399 9427

 

Walbrook PR Ltd

 +44 (0) 20 7933 8780

Paul Cornelius / Nick Rome / Sam Allen

 tekcapital@walbrookpr.com

 

Tekcapital plc - The World's Largest University Network for Open Innovation

Tekcapital's objective is to create value from investing in new, university-developed intellectual properties. Additionally, using its proprietary discovery search engine, linked to 4,500+ universities in 160 countries, coupled with expert scientific review, Tekcapital provides a range of IP investment services to make it easy for organisations to find, evaluate, acquire and license university-developed technology. Tekcapital plc is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in Oxford, in the UK. For more information, please visit www.tekcapital.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAEVLFBVBFZFBX
Date   Source Headline
27th Mar 202012:45 pmRNSHolding(s) in Company
26th Mar 20208:00 amRNSPortfolio Company Update:
26th Mar 20207:00 amRNSPortfolio Company Update: Lucyd
24th Mar 20207:00 amRNSSalarius confirms store roll out
23rd Mar 20202:59 pmRNSPortfolio Company Update
23rd Mar 202010:56 amRNSHolding(s) in Company
16th Mar 20209:15 amRNSBelluscura plc filing of a patent
4th Mar 20207:00 amRNSSalarius secures contract sales partner
2nd Mar 20207:00 amRNSSalarius North American distribution agreement
28th Feb 20207:00 amRNSTotal Voting Rights
12th Feb 20203:09 pmRNSHolding(s) in Company
10th Feb 20202:12 pmRNSHolding(s) in Company
10th Feb 20207:00 amRNSStrategy/Company/Ops Update
7th Feb 20204:03 pmRNSHolding(s) in Company
6th Feb 202012:45 pmRNSPlacing to raise £740,000
24th Jan 20207:00 amRNSSalarius new major food contract
20th Jan 20207:00 amRNSLucyd launch of new bluetooth-enabled Glasses
16th Jan 20207:00 amRNSExhibit At AUTM 2020
7th Jan 20207:00 amRNSAppointment of Director
17th Dec 20197:00 amRNSPortfolio Company Update: Lucyd
12th Dec 20197:00 amRNSPortfolio Company Update
2nd Dec 20191:09 pmRNSBoard Changes
1st Nov 20197:00 amRNSChange of Adviser
16th Oct 20197:00 amRNSPortfolio Company Update
16th Sep 20199:07 amRNSShare Options
2nd Sep 20197:00 amRNSPortfolio Company Update
22nd Aug 20197:00 amRNSHalf-year Report
15th Aug 20197:00 amRNSPortfolio Update: Lucyd Launches Sherman Shades
12th Aug 20197:00 amRNSSalarius Files Additional Patent for MicroSalt®
6th Aug 20197:00 amRNSBelluscura raises £750,000 of additional funding
5th Aug 20193:21 pmRNSHolding(s) in Company - Replacement
2nd Aug 20194:15 pmRNSHolding(s) in Company
1st Aug 201911:35 amRNSHolding(s) in Company
1st Aug 201911:34 amRNSHolding(s) in Company
25th Jul 20197:00 amRNSInvestor Conference Call
22nd Jul 20197:00 amRNSExpansion of Tekcapital services in Mexico
16th Jul 20197:00 amRNSNotice of Investor Conference Call
11th Jul 20197:00 amRNSPlacing to raise £0.75 million
27th Jun 20197:00 amRNSGuident Acquires Additional IP
26th Jun 20197:00 amRNSBelluscura likely to receive FDA clearance in 2019
25th Jun 20197:00 amRNSGuident Acquires Additional IP
24th Jun 20197:00 amRNSSalarius Secures New Order for MicroSalt®
13th Jun 20197:00 amRNSSalarius Secures & Delivers Follow-on Order
14th May 20197:00 amRNSLucyd Launches Loud 2.0 Eyewear Line
3rd May 20197:00 amRNSFlorida Legislature Approves Autonomous Vehicles
29th Apr 20197:00 amRNSGuident Files Additional Patent
24th Apr 20197:00 amRNSPortfolio company, Belluscura plc, raises £500,730
23rd Apr 201911:05 amRNSSecond Price Monitoring Extn
23rd Apr 201911:00 amRNSPrice Monitoring Extension
23rd Apr 20197:00 amRNSSalarius secures first commercial order

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.